Acute effects of intracoronary enoximone on hemodynamics, myocardial perfusion and regional wall motion;Akutauswirkungen von Enoximon nach intrakoronarer Applikation auf die Hamodynamik, Myokardperfusion und die regionale Wandbewegung

Zeitschrift fur Kardiologie

Volumn 85, Issue 11, 1996, Pages 856-867

  Mitrovic, V ^a   Strasser, R ^a   Berwing, K ^a   Thormann, J ^a   Schlepper, M ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

diastolic ventricular function; hemodynamics; intracoronary enoximone; myocardial perfusion

Indexed keywords

ENOXIMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE PERFUSION; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE;

ADULT; AGED; CARDIAC PACING, ARTIFICIAL; CORONARY CIRCULATION; CORONARY DISEASE; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; ENOXIMONE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSION PUMPS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0029821611     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Aguirre FV, Pearson AC, Lewen MK, McCluskey M, Labowitz, AJ (1989) Usefulness of Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 63:1098
2. Alousi AA, Canter JM, Montenaro MJ, Fort DJ, Ferrari RA (1983) Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals. J Cardiovasc Pharmacol 5:792
3. Alousi AA, Farah AE, Lesher GY, Opalka CF Jr (1979) Cardiotonic activity of amrinone-WIN 40680. Circ Res 45:666
4. Alousi AA, Stankus GP, Stuart JC, Walton LH (1984) Characterization of the cardiotonic effects of milrinon, a new potent cardiac bipyridine, on isolated tissues from several animal species. J Cardiovasc Pharmacol 5:804
5. Amin DK, Shah PK, Hulse S, Shellock FG, Swan HJC (1984) Myocardial metabolic and hemodynamic effects of intravenous MDL 17.043, a new Cardiotonic drug, in patients with chronic severe heart failure. Am Heart J 108:1285
6. Appleton CP, Hatle LK, Popp RL (1988) Relation of transmitral flow velocity palterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12:426
7. Arbogast R, Brandt C, Haegele KD, Fincker JL, Schechter PJ (1983) Hemodynamic effects of MDL 17.043, a new cardiotonic agent, in patients with congestive heart failure: Comparison with sodium nitroprusside. J Cardiovasc Pharmacol 5:998
8. Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W (1983) Evaluation of a new bipyridine inotropic agent, milrinone, in patients with severe congestive heart failure. N Engl J Med 309:748
9. Bendersky R, Chatterjee K, Parmley WW, Brundage BH, Ports TA (1981) Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics. Am J Cardiol 48:554
10. Benotti JR, Grossman W, Braunwald E, Davalos DD, Alousi AA (1978) Hemodynamic assessment of amrinone: a new inotropic agent. N Engl J Med 299:1373
11. Benotti JR, Grossman W, Braunwald E (1980) Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62:28
12. Berk MR, Xie G, Kwan OL, Knapp C, Evans J, Kotchen T, Kotchen JM, DeMaria AN (1990) Reduction of left ventricular preload by lower body negative pressure alters Doppler transmitral filling patterns. J Am Coll Cardiol 16:1387
13. Berwing K (ed) (1993) Myokardiale Kontrastechokardiographie. Schuttauer Verlag, Stuttgart New York, pp 42
14. Bryg RJ, Pearson AC, Williams DA, Labowitz, AJ (1987) Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy. Am J Cardiol 59:925
15. Chatterjee K, Kereiakes D, Vicquerat C, Podolin R (1987) Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure. Am J Cardiol 60:37c-41c
16. Choong CY, Herrmann HC, Weyman AE, Fifer MA (1987) Preload dependence on Doppler-derived indexes of left ventricular diastolic function in humans. J Am Coll Cardiol 10:800-808
17. Clancy R, Graham T Jr, Powel W Jr, et al (1967) Inotropic augmentation of myocardial oxygen consumption. Am J Physiol 212:1055
18. Colucci WS, Fiter MA, Jaski BE, Wright RF (1984) Considerations in the hemodynamic evaluation of mixed inotropic-vasodilator agents in patients with congestive heart failure. In: Braunwald E, Sonnenblick EH, Chakrin LW, Schwartz RP Jr (eds) Milrinone: Investigation of New Inotropic Therapy for Congestive Heart Failure. Raven Press, New York, pp 167
19. Colucci WS, Ludmer PL, Wright RF, Arnold JMO, Ganz P, Braunwald E (1985) Myocardial and vascular effects of intracoronary versus intravenous milrinone. Trans Assoc Am Physicians, Washington, DC. 3-6 May, pp 136
20. Daly PA, Chatterjee K, Viquerat CE, et al (1983) RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure. Chest 84:408
21. Demeyere R, Flameng W, TjandraMag TB, Lunkenheimer PP (1990) Myocardial and vascular actions of intracoronary and intravenous enoximone in patients undergoing coronary artery surgery. European Association of Cardiothoracic Anaesthesiologists, 5th Annual Meeting, May 13-16, Vienna, Austria, p 06.7
22. Downes TR, Nomeir A, Stewart K, Mumma M, Kerensky R, Little WC (1990) Effect of alteration in loading conditions on both normal and abnormal patterns of left ventricular filling in healthy individuals. Am J Cardiol 65:377
23. Firth BG, Ratner AV, Grassman ED, Winniford MD, Nicod P, Hillis LD (1984) Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Am J Cardiol 54:1331
24. Graham T Jr, Covell J, Sonnenblick E, et al (1986) Control of myocardial oxygen consumption. Relative influence of contractile state and tension development. J Clin Invest 47:375
25. Grant AM, Harris AL, Alousi AA (1984) Actions of amrinone and milrinone in isolated rabbit renal artery. Fed Proc 43:928
26. Harris AL, Wassey ML, Grant AM, Alousi AA (1984) Direct vasodilating action of milrinone and sodium nitrite in the canine coronary artery. Fed Proc 43:928
27. Honerjäger P, Mitrovic V, Schlepper M (1994) Myokardialer Sauerstoffverbrauch und Verhältnis von Herz- zu Gefäßwirkung bei klinisch eingesetzten Inodilatoren. Med Klinik 89:89
28. Ishida J, Meisner JS, Tsujioka K, Gallo YI, Voran C, Frater RWM, Yellin EL (1986) Lett ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 74:187
29. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS (1985) Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose response relationships and comparison to nitroprusside. J Clin Invest 75:643
30. LeJemtel TH, Keung E, Sonnenblick EH, Ribner HS, Matsumoto M, Davis R, Schwartz W, Alousi AA, Davolos D (1979) Amrinone: A new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 59:1090
31. Lin S, Tak T, Kwanishi DT, McKay CR, Rahimtoola SH, Chandraratna AN (1988) Comparison of Doppler echocardiographic and hemodynamic indexes of left ventricular diastolic properties in coronary artery disease. Am J Cardiol 62:882
32. Ludmer PL, Wright RF, Arnold MO, Ganz P, Baumann E, Colucci WS (1986) Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. Circulation 73:130
33. Maron BJ, Spirito P, Green KJ, Wesley YE, Bonow RO, Arce J (1987) Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 10:733
34. Maskin CS, Sinoway L, Chadwick B, Sonnenblick EH, LeJemtel TH (1983) Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47,203 in patients with severe congestive heart failure. Circulation 67:1065
35. Millard RW, Dube G, Grupp G, Grupp I, Alousi AA, Schwartz A (1980) Direct vasodilatory and positive inotropic actions of amrinone. J Mol Cell Cardiol 12:647
36. Mitrovic V, Oehm E, Minge C, Thürmann P, Schlepper M (1994) Antiischämische Auswirkungen von Gallopamil und Esmolol im intraindividuellen Vergleich bei Patienten mit koronarer Herzkrankheit. Z Kardiol 83:431
37. Monrad ES, Baim DS, Smith HS, et al (1985) Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 71:972
38. Morgagni GL, Pomarici E, Simoni C, Fiorentini G, Rusticali F (1993) Administration of enoximone during cardiac catheterization: a useful test to detect hibernating myocardium. Eur Heart J 14 (Suppl):445
39. Morgagni GL, Pozzati A, Ottani F, Borghi A, Ruggeri A, Puddu GM, Bugiardini R (1990) Effects of enoximone on coronary blood flow in coronary artery disease. Circulation 82 (Suppl III):III-673
40. Neuzner J, Mitrovic V, Pitschner HF, Lissmann H, Schlepper M (1991) Enoximon-Dauerinfusion bei Patienten mit schwerster Herzinsuffizienz, bei dilatativer Kardiomyopathie. Hämodynamische, neurohumorale, laborchemische und klinische Ergebnisse. Z Kardiol 80:397
41. Nishimura RA, Abel MD, Hatle LK, Holmes DR, Housmans PR, Ritman EL, Tajik AJ (1989) Significance of Doppler indices of diastolic filling of the left ventricle: Comparison with invasive hemodynamics in a canine model. Am Heart J 118:1248
42. Phillips RA, Golman ME, Ardeljan M, Arora R, Eison HB, Buyan Y, Krakoff LR (1989) Determinants of abnormal left ventricular filling in early hypertension. J Am Coll Cardiol 14:979
43. Rokey R, Kuo LC, Zoghbi WA, Limacher MC, Quinones MA (1985) Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography. Circulation 71:543
44. Ruggeri A, Borghi A, Ottani F, Cianfrocca C, Pozzati A, Burgiardini R (1992) Acute antiischemic effects of enoximone in patients with stable angina. Clin Pharm Ther 51:151
45. Sonnenblick E, Ross J, Braunwald E (1968) Oxygen consumption of the heart: new concepts of its multifactorial determination. Am J Cardiol 22:328
46. Spirito P, Maron BJ, Bonow RO (1986) Noninvasive assessment of left ventricular diastolic function: Comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol 7:518
47. Stoddard MF, Pearson AC, Kern MJ, Ratcliff J, Mrosek DG, Labovitz AJ (1989) Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans. Circulation 79:1226
48. Taira N (1983) Amrinone. Nippon Rinsho 41:15
49. Takenaka K, Dabestani A, Gardin JM, Russell D, Clark S, Allfie A, Henry WL (1986) Pulsed Doppler echocardiographic study of left ventricular filling in dilated cardiomyopathy. Am J Cardiol 58:143
50. Thormann J, Kramer W, Kindler M, Kremer P, Schlepper M (1987) Bestimmung der Wirkkomponenten von Amrinon durch kontinuierliche Analyse der Druck-Volumenbeziehung; Anwendung der Conductance-(Volumen-)Kathetertechnik und der schnellen Laständerung durch Ballonokklusion der Vena cava inferior. Z Kardiol 76:530
51. Thormann J, Kramer W, Neuss H, Bahawar H, Schlepper M (1985) Analysis of the efficacy of the new cardiotonic agent TA-064. Am Heart J 110:426
52. Uretsky BF, Generalovich T, Reddy PS, Spangenberg RB, Follunsbee WP (1983) The acute hemodynamic effects of a new agent, MDL 17.043 in the treatment of congestive heart failure. Circulation 67:823
53. Wada Y, Taira N (1986) Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations. Heart Vessels 2 (Suppl 1):29
54. Weber KT, Janicki JS, Jain MC (1986) Enoximone (MDL 17.043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol 58:589
55. Wilmshurst PT, Thompson DS, Dittrich HC, Dawson JR, Walker JM, Jenkins BS, Coltart DJ, Webb-Peploe MM (1982) Effects of intravenous and intracoronary amrinone in congestive heart failure. Circulation 66 (Supp II):37
56. Wilmshurst PT, Thompson DS, Jenkins BS, Colthart DJ, Webb-Peploe MM (1983) Hemodynamic effects of intravenous amrinone in patients with impaired left ventricular function. Br Heart J 49:77
57. Wilmshurst PT, Thompson DS, Suhl SM, Jenkins BS, Coltart DJ, Webb-Peploe MM (1984) Comparison of the effects of amrinone and sodium nitroprusside on nemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy. Br Heart J 52:38
58. Wilmshurst PT, Walker JM, Fry CH, Mounsey JP, Twort CHC, Williams BT, Davies MJ, Webb-Peploe MM (1984) Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res 18:302